DaVita

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DaVita and other ETFs, options, and stocks.

About DVA

DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. 

CEO
Javier J. Rodriguez
CEOJavier J. Rodriguez
Employees
78,000
Employees78,000
Headquarters
Denver, Colorado
HeadquartersDenver, Colorado
Founded
1994
Founded1994
Employees
78,000
Employees78,000

DVA Key Statistics

Market cap
11.89B
Market cap11.89B
Price-Earnings ratio
14.91
Price-Earnings ratio14.91
Dividend yield
—
Dividend yield—
Average volume
740.08K
Average volume740.08K
High today
$187.94
High today$187.94
Low today
$176.38
Low today$176.38
Open price
$176.45
Open price$176.45
Volume
931.03K
Volume931.03K
52 Week high
$247.49
52 Week high$247.49
52 Week low
$101.00
52 Week low$101.00

Stock Snapshot

The current DaVita(DVA) stock price is $187.94, with a market capitalization of 11.89B. The stock trades at a price-to-earnings (P/E) ratio of 14.91.

On 2026-10-23, DaVita(DVA) stock traded between a low of $176.38 and a high of $187.94. Shares are currently priced at $187.94, which is +6.6% above the low and 0.0% below the high.

DaVita(DVA) shares are trading with a volume of 931.03K, against a daily average of 740.08K.

During the past year, DaVita(DVA) stock moved between $101.00 at its lowest and $247.49 at its peak.

During the past year, DaVita(DVA) stock moved between $101.00 at its lowest and $247.49 at its peak.

DVA News

MarketWatch 12h
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch

...

DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
Simply Wall St 20h
DaVita Fell On Kidney Care Policy News, Is The Stock Trading At A Discount?

DaVita (DVA) is back in focus after the U.S. Department of Health and Human Services outlined a kidney care plan that pushed the stock down 7.1%, highlighting p...

DaVita Fell On Kidney Care Policy News, Is The Stock Trading At A Discount?
TipRanks 2d
TD says HHS charitable activity review recommendation near-term risk for DaVita

TD Cowen notes that HSS “unexpectedly” released a “Kidney Care National Plan,” making a number of policy recommendations. The firm sees the charitable activity...

Analyst ratings

45%

of 11 ratings
Buy
45.5%
Hold
45.5%
Sell
9.1%

More DVA News

Simply Wall St 7d
Kidney Research Push Might Change The Case For Investing In DaVita Stock

DaVita recently outlined plans to present seven kidney care studies at ASN Kidney Week 2026, covering middle molecule clearance, home dialysis practices and pat...

Kidney Research Push Might Change The Case For Investing In DaVita Stock

People also own

Based on the portfolios of people who own DVA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.